| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 8 | 2021 | 449 | 1.850 |
Why?
|
| Autophagy | 8 | 2022 | 429 | 1.810 |
Why?
|
| Immunologic Memory | 6 | 2022 | 200 | 1.740 |
Why?
|
| Autoimmunity | 4 | 2021 | 182 | 1.470 |
Why?
|
| Apoptosis | 14 | 2022 | 1946 | 1.460 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2020 | 452 | 1.140 |
Why?
|
| Mitochondrial Proteins | 4 | 2022 | 253 | 0.940 |
Why?
|
| B-Lymphocytes | 6 | 2020 | 551 | 0.850 |
Why?
|
| Lymphocyte Activation | 9 | 2020 | 724 | 0.780 |
Why?
|
| Membrane Proteins | 5 | 2022 | 1622 | 0.760 |
Why?
|
| HIV-1 | 2 | 2022 | 488 | 0.710 |
Why?
|
| Self Tolerance | 2 | 2011 | 6 | 0.630 |
Why?
|
| Viruses | 1 | 2020 | 125 | 0.610 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 137 | 0.590 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2012 | 169 | 0.590 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 213 | 0.590 |
Why?
|
| Protein-Tyrosine Kinases | 10 | 2003 | 235 | 0.560 |
Why?
|
| Virus Diseases | 1 | 2020 | 290 | 0.550 |
Why?
|
| Immunization | 2 | 2015 | 315 | 0.510 |
Why?
|
| Caspases | 4 | 2008 | 168 | 0.500 |
Why?
|
| T-Lymphocytes | 9 | 2021 | 1812 | 0.490 |
Why?
|
| Mitochondria | 6 | 2022 | 757 | 0.470 |
Why?
|
| Energy Metabolism | 1 | 2020 | 814 | 0.460 |
Why?
|
| Mice | 22 | 2022 | 19055 | 0.460 |
Why?
|
| Animals | 34 | 2022 | 36557 | 0.450 |
Why?
|
| bcl-X Protein | 3 | 2012 | 32 | 0.450 |
Why?
|
| Caspase 9 | 4 | 2020 | 76 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 3 | 2012 | 182 | 0.420 |
Why?
|
| Cytological Techniques | 1 | 2013 | 17 | 0.400 |
Why?
|
| HIV Infections | 2 | 2022 | 2075 | 0.390 |
Why?
|
| Adoptive Transfer | 5 | 2022 | 241 | 0.380 |
Why?
|
| Perforin | 1 | 2011 | 26 | 0.370 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2012 | 625 | 0.370 |
Why?
|
| Mice, Knockout | 9 | 2022 | 4016 | 0.370 |
Why?
|
| Erythropoiesis | 2 | 2008 | 43 | 0.370 |
Why?
|
| fas Receptor | 1 | 2011 | 50 | 0.370 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2011 | 276 | 0.340 |
Why?
|
| Hepatitis B virus | 6 | 1997 | 142 | 0.330 |
Why?
|
| Reticulocytes | 3 | 2008 | 44 | 0.330 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 133 | 0.320 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2011 | 247 | 0.310 |
Why?
|
| Interferon-gamma | 1 | 2011 | 538 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 10 | 2022 | 4879 | 0.290 |
Why?
|
| Influenza, Human | 1 | 2014 | 699 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 507 | 0.260 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 2 | 2022 | 18 | 0.260 |
Why?
|
| Flow Cytometry | 3 | 2015 | 837 | 0.250 |
Why?
|
| Severe Combined Immunodeficiency | 4 | 2003 | 108 | 0.250 |
Why?
|
| Cell Survival | 5 | 2015 | 890 | 0.240 |
Why?
|
| Signal Transduction | 11 | 2008 | 4934 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 6 | 2003 | 1433 | 0.220 |
Why?
|
| Inflammation | 1 | 2011 | 1595 | 0.210 |
Why?
|
| Mice, Inbred MRL lpr | 2 | 2021 | 20 | 0.210 |
Why?
|
| Neoplasm Proteins | 1 | 2007 | 719 | 0.200 |
Why?
|
| Transcription Factor AP-1 | 2 | 2022 | 112 | 0.200 |
Why?
|
| Autoantibodies | 2 | 2021 | 468 | 0.200 |
Why?
|
| Interleukin-2 | 4 | 2003 | 252 | 0.190 |
Why?
|
| Virus Latency | 1 | 2022 | 64 | 0.180 |
Why?
|
| Tuberculosis Vaccines | 1 | 2021 | 13 | 0.180 |
Why?
|
| Virus Activation | 1 | 2022 | 85 | 0.180 |
Why?
|
| Hepatitis B Core Antigens | 3 | 1996 | 14 | 0.180 |
Why?
|
| Cell Separation | 2 | 2013 | 234 | 0.180 |
Why?
|
| Terpenes | 1 | 2021 | 30 | 0.180 |
Why?
|
| Mucous Membrane | 1 | 2021 | 92 | 0.180 |
Why?
|
| Autoantigens | 1 | 2021 | 118 | 0.170 |
Why?
|
| Macaca mulatta | 1 | 2022 | 513 | 0.170 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 1995 | 136 | 0.170 |
Why?
|
| Germinal Center | 1 | 2020 | 38 | 0.170 |
Why?
|
| Vaccines, Synthetic | 1 | 2021 | 322 | 0.170 |
Why?
|
| NF-kappa B | 2 | 2022 | 482 | 0.160 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2011 | 14 | 0.160 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2011 | 73 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 1765 | 0.160 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 320 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2019 | 105 | 0.160 |
Why?
|
| Spleen | 2 | 2013 | 292 | 0.150 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 825 | 0.150 |
Why?
|
| Adenoviridae | 1 | 2021 | 609 | 0.150 |
Why?
|
| Transcription Factors | 5 | 2015 | 2738 | 0.150 |
Why?
|
| DNA-Binding Proteins | 7 | 2003 | 2178 | 0.150 |
Why?
|
| Janus Kinase 3 | 8 | 2003 | 16 | 0.140 |
Why?
|
| Cytokines | 5 | 2021 | 1401 | 0.140 |
Why?
|
| Cytochromes c | 2 | 2008 | 52 | 0.140 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 266 | 0.140 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 32 | 0.140 |
Why?
|
| Immunoglobulin gamma-Chains | 1 | 1997 | 2 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 1997 | 36 | 0.140 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 408 | 0.140 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2017 | 63 | 0.140 |
Why?
|
| Acute Disease | 1 | 2020 | 1192 | 0.130 |
Why?
|
| Multigene Family | 2 | 2012 | 324 | 0.130 |
Why?
|
| Influenza A virus | 1 | 2017 | 152 | 0.130 |
Why?
|
| Enzyme Activation | 4 | 2007 | 650 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2015 | 3188 | 0.120 |
Why?
|
| Haptens | 1 | 2015 | 7 | 0.120 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2015 | 13 | 0.120 |
Why?
|
| Dimerization | 2 | 2007 | 153 | 0.120 |
Why?
|
| Hemocyanins | 1 | 2015 | 27 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2003 | 322 | 0.120 |
Why?
|
| Lung | 2 | 2017 | 1577 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 773 | 0.110 |
Why?
|
| Transfection | 7 | 2002 | 1096 | 0.110 |
Why?
|
| Humans | 28 | 2021 | 134156 | 0.110 |
Why?
|
| Point Mutation | 4 | 2000 | 362 | 0.110 |
Why?
|
| COS Cells | 5 | 2003 | 284 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2015 | 1332 | 0.100 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2015 | 260 | 0.100 |
Why?
|
| Mice, Transgenic | 2 | 2011 | 2539 | 0.100 |
Why?
|
| Bromodeoxyuridine | 1 | 2013 | 59 | 0.100 |
Why?
|
| HeLa Cells | 6 | 2003 | 838 | 0.100 |
Why?
|
| Jurkat Cells | 3 | 2008 | 95 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2014 | 188 | 0.100 |
Why?
|
| Immunity, Innate | 2 | 2017 | 417 | 0.100 |
Why?
|
| Antibodies, Viral | 2 | 2017 | 1211 | 0.090 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 214 | 0.090 |
Why?
|
| Biological Assay | 1 | 2012 | 111 | 0.090 |
Why?
|
| Phenotype | 2 | 2020 | 4598 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 275 | 0.090 |
Why?
|
| Protein Binding | 4 | 2007 | 1859 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2012 | 503 | 0.090 |
Why?
|
| Milk Proteins | 2 | 2003 | 92 | 0.090 |
Why?
|
| Models, Immunological | 1 | 2010 | 38 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4808 | 0.080 |
Why?
|
| Gene Expression | 1 | 2015 | 1621 | 0.080 |
Why?
|
| Liver | 2 | 1994 | 1879 | 0.080 |
Why?
|
| Base Sequence | 8 | 2003 | 3180 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 2003 | 3980 | 0.080 |
Why?
|
| Adaptive Immunity | 1 | 2010 | 96 | 0.080 |
Why?
|
| Cell Communication | 1 | 2010 | 188 | 0.080 |
Why?
|
| Influenza Vaccines | 1 | 2014 | 497 | 0.080 |
Why?
|
| Peptides | 1 | 2013 | 863 | 0.080 |
Why?
|
| Genes, Dominant | 2 | 2007 | 253 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2002 | 1440 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 48 | 0.070 |
Why?
|
| Anemia, Hemolytic | 1 | 2008 | 32 | 0.070 |
Why?
|
| Erythroid Cells | 1 | 2008 | 24 | 0.070 |
Why?
|
| Trans-Activators | 4 | 2003 | 840 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 1351 | 0.070 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2007 | 13 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 787 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 4 | 1999 | 1107 | 0.070 |
Why?
|
| Mutation | 2 | 2001 | 6338 | 0.070 |
Why?
|
| Models, Biological | 2 | 2012 | 1539 | 0.060 |
Why?
|
| Caspase Inhibitors | 1 | 2006 | 35 | 0.060 |
Why?
|
| Antibodies, Antinuclear | 1 | 2006 | 31 | 0.060 |
Why?
|
| RNA, Viral | 2 | 2020 | 563 | 0.060 |
Why?
|
| Binding Sites | 6 | 2000 | 1384 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 596 | 0.060 |
Why?
|
| Phosphoproteins | 2 | 2000 | 459 | 0.060 |
Why?
|
| Female | 6 | 2021 | 71928 | 0.060 |
Why?
|
| RNA Interference | 2 | 2022 | 548 | 0.060 |
Why?
|
| Time Factors | 1 | 2015 | 6610 | 0.060 |
Why?
|
| Viral Proteins | 1 | 2006 | 360 | 0.050 |
Why?
|
| Cell Line, Transformed | 2 | 2003 | 169 | 0.050 |
Why?
|
| Male | 5 | 2021 | 66127 | 0.050 |
Why?
|
| Piperazines | 2 | 2020 | 257 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 1 | 2006 | 1089 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 61 | 0.050 |
Why?
|
| Caspase 8 | 1 | 2002 | 24 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2002 | 60 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2002 | 141 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 71 | 0.050 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 79 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2022 | 19 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2002 | 1148 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2000 | 912 | 0.050 |
Why?
|
| Galectins | 1 | 2021 | 26 | 0.050 |
Why?
|
| Cathepsins | 1 | 2021 | 26 | 0.050 |
Why?
|
| Autophagosomes | 1 | 2021 | 30 | 0.050 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 131 | 0.040 |
Why?
|
| Forecasting | 1 | 2002 | 377 | 0.040 |
Why?
|
| BCG Vaccine | 1 | 2021 | 112 | 0.040 |
Why?
|
| Organophosphates | 1 | 2020 | 21 | 0.040 |
Why?
|
| Longevity | 1 | 2022 | 160 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2020 | 112 | 0.040 |
Why?
|
| Pyrimidinones | 1 | 2020 | 60 | 0.040 |
Why?
|
| Azepines | 1 | 2020 | 65 | 0.040 |
Why?
|
| Cattle | 1 | 2021 | 589 | 0.040 |
Why?
|
| Viral Core Proteins | 1 | 1999 | 23 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2003 | 328 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2022 | 721 | 0.040 |
Why?
|
| Triazoles | 1 | 2020 | 142 | 0.040 |
Why?
|
| Lysosomes | 1 | 2021 | 265 | 0.040 |
Why?
|
| DNA Replication | 1 | 2021 | 366 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2022 | 372 | 0.040 |
Why?
|
| Catalytic Domain | 1 | 2000 | 178 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2001 | 2795 | 0.040 |
Why?
|
| Genes, p53 | 1 | 1999 | 234 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2003 | 947 | 0.040 |
Why?
|
| Pyridines | 1 | 2020 | 250 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 117 | 0.040 |
Why?
|
| Kidney | 1 | 2006 | 1421 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 416 | 0.040 |
Why?
|
| Growth | 1 | 1999 | 106 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 1306 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1996 | 139 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 212 | 0.040 |
Why?
|
| Cell Line | 4 | 2012 | 2864 | 0.040 |
Why?
|
| Genes, T-Cell Receptor delta | 1 | 2017 | 8 | 0.040 |
Why?
|
| Genetic Vectors | 1 | 2021 | 970 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1997 | 127 | 0.030 |
Why?
|
| Homeostasis | 1 | 2022 | 751 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2017 | 130 | 0.030 |
Why?
|
| Hepatitis B e Antigens | 1 | 1996 | 13 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 218 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2001 | 806 | 0.030 |
Why?
|
| Protein Kinases | 1 | 1998 | 345 | 0.030 |
Why?
|
| Cigarette Smoking | 1 | 2017 | 80 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2000 | 628 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 171 | 0.030 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1996 | 94 | 0.030 |
Why?
|
| Vaccination | 1 | 2021 | 1017 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 1994 | 4 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2003 | 1187 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 1999 | 797 | 0.030 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 1995 | 54 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 1994 | 28 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 1994 | 50 | 0.030 |
Why?
|
| Genes, Viral | 1 | 1994 | 186 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 1138 | 0.030 |
Why?
|
| DNA, Viral | 1 | 1995 | 500 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 1996 | 1761 | 0.030 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 37 | 0.030 |
Why?
|
| Virus Replication | 1 | 1996 | 637 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2012 | 164 | 0.020 |
Why?
|
| Primary Cell Culture | 1 | 2012 | 110 | 0.020 |
Why?
|
| Phosphorylation | 3 | 2003 | 1713 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 252 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2266 | 0.020 |
Why?
|
| STAT5 Transcription Factor | 2 | 2003 | 90 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 4 | 0.020 |
Why?
|
| Nitrophenols | 1 | 2008 | 16 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 63 | 0.020 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 609 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 178 | 0.020 |
Why?
|
| Transcriptional Activation | 2 | 2000 | 504 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2008 | 287 | 0.020 |
Why?
|
| Restriction Mapping | 2 | 1995 | 193 | 0.010 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2003 | 9 | 0.010 |
Why?
|
| Transcription Initiation Site | 1 | 2003 | 34 | 0.010 |
Why?
|
| Base Composition | 1 | 2003 | 75 | 0.010 |
Why?
|
| Codon, Nonsense | 1 | 2003 | 145 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2003 | 59 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2003 | 443 | 0.010 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2001 | 12 | 0.010 |
Why?
|
| Staurosporine | 1 | 2001 | 22 | 0.010 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2001 | 24 | 0.010 |
Why?
|
| Catalysis | 1 | 2001 | 138 | 0.010 |
Why?
|
| src-Family Kinases | 1 | 2001 | 97 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 357 | 0.010 |
Why?
|
| src Homology Domains | 1 | 2000 | 35 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2001 | 298 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2000 | 31 | 0.010 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 1 | 2000 | 26 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2003 | 811 | 0.010 |
Why?
|
| Genes, myc | 1 | 2000 | 107 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2000 | 69 | 0.010 |
Why?
|
| Growth Substances | 1 | 2000 | 114 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 633 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1999 | 80 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 3798 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2000 | 313 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 1999 | 92 | 0.010 |
Why?
|
| Cyclins | 1 | 1999 | 105 | 0.010 |
Why?
|
| Janus Kinase 1 | 1 | 1999 | 11 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1999 | 44 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1999 | 69 | 0.010 |
Why?
|
| Janus Kinase 2 | 1 | 2000 | 134 | 0.010 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 1999 | 94 | 0.010 |
Why?
|
| Pyrimidines | 1 | 2001 | 418 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1999 | 1007 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 539 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1999 | 320 | 0.010 |
Why?
|
| Biological Evolution | 1 | 1999 | 256 | 0.010 |
Why?
|
| Hepacivirus | 1 | 1999 | 273 | 0.010 |
Why?
|
| Tyrosine | 1 | 1997 | 161 | 0.010 |
Why?
|
| Regulatory Factor X1 | 1 | 1997 | 6 | 0.010 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 1997 | 10 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1997 | 52 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 472 | 0.010 |
Why?
|
| Metallothionein | 1 | 1996 | 15 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 1999 | 1417 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 33 | 0.010 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 1996 | 29 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 295 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2915 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1996 | 151 | 0.010 |
Why?
|
| Methylation | 1 | 1996 | 232 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 729 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1999 | 1627 | 0.010 |
Why?
|
| Hepatitis B | 1 | 1996 | 173 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1995 | 272 | 0.010 |
Why?
|
| DNA | 1 | 2000 | 1682 | 0.010 |
Why?
|
| Virion | 1 | 1995 | 151 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 434 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 2669 | 0.010 |
Why?
|
| DNA Primers | 1 | 1995 | 672 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1997 | 678 | 0.010 |
Why?
|
| Neoplasms | 2 | 1999 | 3038 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1995 | 357 | 0.010 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 1993 | 20 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2000 | 1923 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 993 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 1993 | 189 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1993 | 691 | 0.010 |
Why?
|
| Infant | 1 | 2003 | 13240 | 0.000 |
Why?
|
| United States | 1 | 2003 | 11763 | 0.000 |
Why?
|